If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> ARCHIVE<br /> Volume 109 Number 1 JANuArY 2014<br /> www.amjgastro.com<br /> official publication of the american college of gastroenterology<br /> leading articles of the month<br /> Clinical and Systematic Reviews<br /> 23 The Role of Thiopurines in Reducing the Need for Surgical<br /> Resection in Crohn’s Disease: A Systematic Review<br /> and Meta-Analysis CME<br /> S. Chatu, V. Subramanian, S. Saxena and R.C.G. Pollok<br /> Esophagus<br /> 52 Objective Manometric Criteria for the Rumination Syndrome<br /> B.F. Kessing, A.J. Bredenoord and A.J.P.M. Smout<br /> Stomach<br /> 60 Effect of Helicobacter pylori Eradication on Metachronous<br /> Recurrence After Endoscopic Resection of Gastric Neoplasm<br /> S.E. Bae, H.-Y. Jung, J. Kang, Y.S. Park, S. Baek, J.-H. Jung, J.Y. Choi,<br /> M.-Y. Kim, J.Y. Ahn, K.-S. Choi, D.H. Kim, J.H. Lee, K.D. Cho<a title="AJG_Vol.109_No.2 page 1" href="http://viewer.zmags.com/publication/3da21923?page=1"> ARCHIVE Volume 109 Number 1 JANuArY 2014 www.amj</a> <a title="AJG_Vol.109_No.2 page 2" href="http://viewer.zmags.com/publication/3da21923?page=2"> VOLUME 109 NUMBER 2 FEBRUARY 2014 www.amjgastro.c</a> <a title="AJG_Vol.109_No.2 page 3" href="http://viewer.zmags.com/publication/3da21923?page=3"> Seeing is believing MoviPrep® has proven 89% exc</a> <a title="AJG_Vol.109_No.2 page 4" href="http://viewer.zmags.com/publication/3da21923?page=4"> MOVIPREP® (PEG-3350, sodium sulfate, sodium chlor</a> <a title="AJG_Vol.109_No.2 page 5" href="http://viewer.zmags.com/publication/3da21923?page=5"> www.amjgastro.com The American Journal of</a> <a title="AJG_Vol.109_No.2 page 6" href="http://viewer.zmags.com/publication/3da21923?page=6"> 72% BUY STORE OF DOCTORS BRAND AN</a> <a title="AJG_Vol.109_No.2 page 7" href="http://viewer.zmags.com/publication/3da21923?page=7"> What is Pharma Solutions? It is: A division at N</a> <a title="AJG_Vol.109_No.2 page 8" href="http://viewer.zmags.com/publication/3da21923?page=8"> Submit your application for the ACG 2014 Internat</a> <a title="AJG_Vol.109_No.2 page 9" href="http://viewer.zmags.com/publication/3da21923?page=9"> official publication of the american college</a> <a title="AJG_Vol.109_No.2 page 10" href="http://viewer.zmags.com/publication/3da21923?page=10"> DOWENEEDMOREIBD? FOCUSIN Understanding the pathop</a> <a title="AJG_Vol.109_No.2 page 11" href="http://viewer.zmags.com/publication/3da21923?page=11"> WE'RE CHANGING THE NORM FOR PATIENTS WITH </a> <a title="AJG_Vol.109_No.2 page 12" href="http://viewer.zmags.com/publication/3da21923?page=12"> The following is a brief summary only; see full P</a> <a title="AJG_Vol.109_No.2 page 13" href="http://viewer.zmags.com/publication/3da21923?page=13"> Lowest volume of active prep solution— only 10 oz</a> <a title="AJG_Vol.109_No.2 page 14" href="http://viewer.zmags.com/publication/3da21923?page=14"> An island of squamous epithelium in a background </a> <a title="AJG_Vol.109_No.2 page 15" href="http://viewer.zmags.com/publication/3da21923?page=15"> CONTENTS </a> <a title="AJG_Vol.109_No.2 page 16" href="http://viewer.zmags.com/publication/3da21923?page=16"> www.amjgastro.com </a> <a title="AJG_Vol.109_No.2 page 17" href="http://viewer.zmags.com/publication/3da21923?page=17"> Average first decision 22 days AOP 25 business day</a> <a title="AJG_Vol.109_No.2 page 18" href="http://viewer.zmags.com/publication/3da21923?page=18"> NEW from Amneal Pharmaceuticals Esomeprazole th</a> <a title="AJG_Vol.109_No.2 page 19" href="http://viewer.zmags.com/publication/3da21923?page=19"> BRIEF SUMMARY ESOMEPRAZOLE STRONTIUM delayed-rel</a> <a title="AJG_Vol.109_No.2 page 20" href="http://viewer.zmags.com/publication/3da21923?page=20"> DRUG INTERACTIONS Interference with Antiretrovira</a> <a title="AJG_Vol.109_No.2 page 21" href="http://viewer.zmags.com/publication/3da21923?page=21"> Be at the forefront of Endoscopy. Join us for our</a> <a title="AJG_Vol.109_No.2 page 22" href="http://viewer.zmags.com/publication/3da21923?page=22"> </a> <a title="AJG_Vol.109_No.2 page 23" href="http://viewer.zmags.com/publication/3da21923?page=23"> </a> <a title="AJG_Vol.109_No.2 page 24" href="http://viewer.zmags.com/publication/3da21923?page=24"> Recruiting the best researchers and medical profe</a> <a title="AJG_Vol.109_No.2 page 25" href="http://viewer.zmags.com/publication/3da21923?page=25"> INDICATION SOVALDI is a hepatitis C virus (HCV) n</a> <a title="AJG_Vol.109_No.2 page 26" href="http://viewer.zmags.com/publication/3da21923?page=26"> NOW AVAILABLE WARNINGS AND PRECAUTIONS · Pr</a> <a title="AJG_Vol.109_No.2 page 27" href="http://viewer.zmags.com/publication/3da21923?page=27"> SOVALDI™ (sofosbuvir) tablets Brief summary of </a> <a title="AJG_Vol.109_No.2 page 28" href="http://viewer.zmags.com/publication/3da21923?page=28"> Brief Summary (cont.) Table 2 Percentage of Subj</a> <a title="AJG_Vol.109_No.2 page 29" href="http://viewer.zmags.com/publication/3da21923?page=29"> </a> <a title="AJG_Vol.109_No.2 page 30" href="http://viewer.zmags.com/publication/3da21923?page=30"> Crack the Case Wide Open Don't let vague GI sympt</a> <a title="AJG_Vol.109_No.2 page 31" href="http://viewer.zmags.com/publication/3da21923?page=31"> ACG/LGS Regional Postgraduate Course March 7-8, </a> <a title="AJG_Vol.109_No.2 page 32" href="http://viewer.zmags.com/publication/3da21923?page=32"> </a> <a title="AJG_Vol.109_No.2 page 33" href="http://viewer.zmags.com/publication/3da21923?page=33"> </a> <a title="AJG_Vol.109_No.2 page 34" href="http://viewer.zmags.com/publication/3da21923?page=34"> RetroView ™ GivesYouThe Power To See It. One loo</a> <a title="AJG_Vol.109_No.2 page 35" href="http://viewer.zmags.com/publication/3da21923?page=35"> In Active, Mild to Moderate Ulcerative Colitis (U</a> <a title="AJG_Vol.109_No.2 page 36" href="http://viewer.zmags.com/publication/3da21923?page=36"> Through the UCERIS Savings Program Now 90% of pa</a> <a title="AJG_Vol.109_No.2 page 37" href="http://viewer.zmags.com/publication/3da21923?page=37"> BRIEF SUMMARY Please see package insert for Full </a> <a title="AJG_Vol.109_No.2 page 38" href="http://viewer.zmags.com/publication/3da21923?page=38"> A significant achievement for patients with fecal </a> <a title="AJG_Vol.109_No.2 page 39" href="http://viewer.zmags.com/publication/3da21923?page=39"> Brief Summary Please consult Package Insert for f</a> <a title="AJG_Vol.109_No.2 page 40" href="http://viewer.zmags.com/publication/3da21923?page=40"> Belladonna Alkaloids and Phenobarbita Brand Don</a> <a title="AJG_Vol.109_No.2 page 41" href="http://viewer.zmags.com/publication/3da21923?page=41"> COLORECTAL CANCER: The “Right” Perspective Adenoc</a> <a title="AJG_Vol.109_No.2 page 42" href="http://viewer.zmags.com/publication/3da21923?page=42"> Importance of thorough adenoma detection during c</a> <a title="AJG_Vol.109_No.2 page 43" href="http://viewer.zmags.com/publication/3da21923?page=43"> NOW AVAILABLE </a> <a title="AJG_Vol.109_No.2 page 44" href="http://viewer.zmags.com/publication/3da21923?page=44"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 45" href="http://viewer.zmags.com/publication/3da21923?page=45"> 146 The red secTion What’s Hot in the red jo</a> <a title="AJG_Vol.109_No.2 page 46" href="http://viewer.zmags.com/publication/3da21923?page=46"> The red secTion 147 What’s Hot in the red jo</a> <a title="AJG_Vol.109_No.2 page 47" href="http://viewer.zmags.com/publication/3da21923?page=47"> 148 THE RED SECTION </a> <a title="AJG_Vol.109_No.2 page 48" href="http://viewer.zmags.com/publication/3da21923?page=48"> colonoscopy in an average-risk patient (6). When </a> <a title="AJG_Vol.109_No.2 page 49" href="http://viewer.zmags.com/publication/3da21923?page=49"> 150 THE RED SECTION a recommendation for r</a> <a title="AJG_Vol.109_No.2 page 50" href="http://viewer.zmags.com/publication/3da21923?page=50"> THE RED SECTION 151 Table 1b. Distribution o</a> <a title="AJG_Vol.109_No.2 page 51" href="http://viewer.zmags.com/publication/3da21923?page=51"> 152 THE RED SECTION Table 3. Crude estimate</a> <a title="AJG_Vol.109_No.2 page 52" href="http://viewer.zmags.com/publication/3da21923?page=52"> guidelines compared with excellent/good bowel cle</a> <a title="AJG_Vol.109_No.2 page 53" href="http://viewer.zmags.com/publication/3da21923?page=53"> 154 THE RED SECTION data Steyer R, W</a> <a title="AJG_Vol.109_No.2 page 54" href="http://viewer.zmags.com/publication/3da21923?page=54"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 55" href="http://viewer.zmags.com/publication/3da21923?page=55"> 156 THE RED SECTION positions were success</a> <a title="AJG_Vol.109_No.2 page 56" href="http://viewer.zmags.com/publication/3da21923?page=56"> THE RED SECTION 157 Table 1. Demographic cha</a> <a title="AJG_Vol.109_No.2 page 57" href="http://viewer.zmags.com/publication/3da21923?page=57"> 158 THE RED SECTION Table 5. Magnitude of i</a> <a title="AJG_Vol.109_No.2 page 58" href="http://viewer.zmags.com/publication/3da21923?page=58"> this option will likely enhance applications to p</a> <a title="AJG_Vol.109_No.2 page 59" href="http://viewer.zmags.com/publication/3da21923?page=59"> 160 The red secTion </a> <a title="AJG_Vol.109_No.2 page 60" href="http://viewer.zmags.com/publication/3da21923?page=60"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 61" href="http://viewer.zmags.com/publication/3da21923?page=61"> 162 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109_No.2 page 62" href="http://viewer.zmags.com/publication/3da21923?page=62"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 63" href="http://viewer.zmags.com/publication/3da21923?page=63"> 164 Ariyaratnam and Subramanian REVIEW over</a> <a title="AJG_Vol.109_No.2 page 64" href="http://viewer.zmags.com/publication/3da21923?page=64"> Thiopurine Use and Nonmelanoma Skin Cancers 16</a> <a title="AJG_Vol.109_No.2 page 65" href="http://viewer.zmags.com/publication/3da21923?page=65"> 166 Ariyaratnam and Subramanian REVIEW Tabl</a> <a title="AJG_Vol.109_No.2 page 66" href="http://viewer.zmags.com/publication/3da21923?page=66"> Thiopurine Use and Nonmelanoma Skin Cancers 16</a> <a title="AJG_Vol.109_No.2 page 67" href="http://viewer.zmags.com/publication/3da21923?page=67"> 168 Ariyaratnam and Subramanian Study na</a> <a title="AJG_Vol.109_No.2 page 68" href="http://viewer.zmags.com/publication/3da21923?page=68"> CONFLICT OF INTEREST Guarantor of the article: Ve</a> <a title="AJG_Vol.109_No.2 page 69" href="http://viewer.zmags.com/publication/3da21923?page=69"> 170 CLINICAL AND SYSTEMATIC REVIEWS </a> <a title="AJG_Vol.109_No.2 page 70" href="http://viewer.zmags.com/publication/3da21923?page=70"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 71" href="http://viewer.zmags.com/publication/3da21923?page=71"> 172 Ness-Jensen et al. an association bet</a> <a title="AJG_Vol.109_No.2 page 72" href="http://viewer.zmags.com/publication/3da21923?page=72"> the categories defined by the World Health Organi</a> <a title="AJG_Vol.109_No.2 page 73" href="http://viewer.zmags.com/publication/3da21923?page=73"> 174 Ness-Jensen et al. ESOPHAGUS Table 1. C</a> <a title="AJG_Vol.109_No.2 page 74" href="http://viewer.zmags.com/publication/3da21923?page=74"> Tobacco Smoking and Gastroesophageal Reflux 17</a> <a title="AJG_Vol.109_No.2 page 75" href="http://viewer.zmags.com/publication/3da21923?page=75"> 176 Ness-Jensen et al. All ESOPHAGUS B</a> <a title="AJG_Vol.109_No.2 page 76" href="http://viewer.zmags.com/publication/3da21923?page=76"> REFERENCES 1. Isolauri J, Laippala P. Prevalence</a> <a title="AJG_Vol.109_No.2 page 77" href="http://viewer.zmags.com/publication/3da21923?page=77"> 178 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.2 page 78" href="http://viewer.zmags.com/publication/3da21923?page=78"> or indeterminate histopathology for BE in patient</a> <a title="AJG_Vol.109_No.2 page 79" href="http://viewer.zmags.com/publication/3da21923?page=79"> 180 Khandwalla et al. Total patients </a> <a title="AJG_Vol.109_No.2 page 80" href="http://viewer.zmags.com/publication/3da21923?page=80"> BE at Endoscopy but No IM on Biopsy 181 Tab</a> <a title="AJG_Vol.109_No.2 page 81" href="http://viewer.zmags.com/publication/3da21923?page=81"> 182 Khandwalla et al. ESOPHAGUS editing man</a> <a title="AJG_Vol.109_No.2 page 82" href="http://viewer.zmags.com/publication/3da21923?page=82"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 83" href="http://viewer.zmags.com/publication/3da21923?page=83"> 184 Knabe et al. ENDOSCOPY postpolypectomy </a> <a title="AJG_Vol.109_No.2 page 84" href="http://viewer.zmags.com/publication/3da21923?page=84"> between the size of the lesions and the rates of </a> <a title="AJG_Vol.109_No.2 page 85" href="http://viewer.zmags.com/publication/3da21923?page=85"> 186 Knabe et al. ENDOSCOPY Table 3. Listing</a> <a title="AJG_Vol.109_No.2 page 86" href="http://viewer.zmags.com/publication/3da21923?page=86"> Long-Term Results After Endoscopic Resection of L</a> <a title="AJG_Vol.109_No.2 page 87" href="http://viewer.zmags.com/publication/3da21923?page=87"> 188 Knabe et al. ENDOSCOPY surveillance str</a> <a title="AJG_Vol.109_No.2 page 88" href="http://viewer.zmags.com/publication/3da21923?page=88"> Study Highlights WHAT IS CURRENT KNOWLEDGE 3Larg</a> <a title="AJG_Vol.109_No.2 page 89" href="http://viewer.zmags.com/publication/3da21923?page=89"> 190 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.2 page 90" href="http://viewer.zmags.com/publication/3da21923?page=90"> to improve modifiable lifestyle factors. By compa</a> <a title="AJG_Vol.109_No.2 page 91" href="http://viewer.zmags.com/publication/3da21923?page=91"> 192 Ratib et al. LIVER Stage of disease We </a> <a title="AJG_Vol.109_No.2 page 92" href="http://viewer.zmags.com/publication/3da21923?page=92"> Occurrence of Liver Cirrhosis in England, 1998–20</a> <a title="AJG_Vol.109_No.2 page 93" href="http://viewer.zmags.com/publication/3da21923?page=93"> 194 Ratib et al. LIVER top 20 most diagnose</a> <a title="AJG_Vol.109_No.2 page 94" href="http://viewer.zmags.com/publication/3da21923?page=94"> Incidence of cirrhosis by etiology, males (1998–2</a> <a title="AJG_Vol.109_No.2 page 95" href="http://viewer.zmags.com/publication/3da21923?page=95"> 196 Ratib et al. The 20 most common cancer</a> <a title="AJG_Vol.109_No.2 page 96" href="http://viewer.zmags.com/publication/3da21923?page=96"> Occurrence of Liver Cirrhosis in England, 1998–20</a> <a title="AJG_Vol.109_No.2 page 97" href="http://viewer.zmags.com/publication/3da21923?page=97"> 198 Ratib et al. LIVER CONFLICT OF INTEREST</a> <a title="AJG_Vol.109_No.2 page 98" href="http://viewer.zmags.com/publication/3da21923?page=98"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 99" href="http://viewer.zmags.com/publication/3da21923?page=99"> 200 Kamal et al. LIVER which may progress t</a> <a title="AJG_Vol.109_No.2 page 100" href="http://viewer.zmags.com/publication/3da21923?page=100"> Determinates of Outcome of Exposure to HCV Genoty</a> <a title="AJG_Vol.109_No.2 page 101" href="http://viewer.zmags.com/publication/3da21923?page=101"> 202 Kamal et al. LIVER The study was monito</a> <a title="AJG_Vol.109_No.2 page 102" href="http://viewer.zmags.com/publication/3da21923?page=102"> proven acute HCV did not clear HCV spontaneously </a> <a title="AJG_Vol.109_No.2 page 103" href="http://viewer.zmags.com/publication/3da21923?page=103"> 204 Kamal et al. Expos</a> <a title="AJG_Vol.109_No.2 page 104" href="http://viewer.zmags.com/publication/3da21923?page=104"> Determinates of Outcome of Exposure to HCV Genoty</a> <a title="AJG_Vol.109_No.2 page 105" href="http://viewer.zmags.com/publication/3da21923?page=105"> 206 Kamal et al. LIVER Table 2. Frequency o</a> <a title="AJG_Vol.109_No.2 page 106" href="http://viewer.zmags.com/publication/3da21923?page=106"> Determinates of Outcome of Exposure to HCV Genoty</a> <a title="AJG_Vol.109_No.2 page 107" href="http://viewer.zmags.com/publication/3da21923?page=107"> 208 Kamal et al. LIVER viral clearance as w</a> <a title="AJG_Vol.109_No.2 page 108" href="http://viewer.zmags.com/publication/3da21923?page=108"> exposure, but mounted T-cell responses only durin</a> <a title="AJG_Vol.109_No.2 page 109" href="http://viewer.zmags.com/publication/3da21923?page=109"> 210 Kamal et al. Medicine, Egypt (2009 to</a> <a title="AJG_Vol.109_No.2 page 110" href="http://viewer.zmags.com/publication/3da21923?page=110"> 36. Page K, Hahn J, Evans J et al. Acute hepatiti</a> <a title="AJG_Vol.109_No.2 page 111" href="http://viewer.zmags.com/publication/3da21923?page=111"> 212 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.2 page 112" href="http://viewer.zmags.com/publication/3da21923?page=112"> patients with inflammatory bowel disease (IBD) tr</a> <a title="AJG_Vol.109_No.2 page 113" href="http://viewer.zmags.com/publication/3da21923?page=113"> 214 Lichtenstein et al. BOWEL DISEASE INFLAM</a> <a title="AJG_Vol.109_No.2 page 114" href="http://viewer.zmags.com/publication/3da21923?page=114"> Malignancy in TREAT Registry Patients With CD </a> <a title="AJG_Vol.109_No.2 page 115" href="http://viewer.zmags.com/publication/3da21923?page=115"> 216 Lichtenstein et al. INFLAMMATORY BOWEL D</a> <a title="AJG_Vol.109_No.2 page 116" href="http://viewer.zmags.com/publication/3da21923?page=116"> Malignancy in TREAT Registry Patients With CD </a> <a title="AJG_Vol.109_No.2 page 117" href="http://viewer.zmags.com/publication/3da21923?page=117"> 218 Lichtenstein et al. INFLAMMATORY BOWEL D</a> <a title="AJG_Vol.109_No.2 page 118" href="http://viewer.zmags.com/publication/3da21923?page=118"> Table 4. Malignancies in the TREAT Registry: impa</a> <a title="AJG_Vol.109_No.2 page 119" href="http://viewer.zmags.com/publication/3da21923?page=119"> 220 Lichtenstein et al. INFLAMMATORY BOWEL D</a> <a title="AJG_Vol.109_No.2 page 120" href="http://viewer.zmags.com/publication/3da21923?page=120"> of drug-derived thioguanine nucleotides into DNA </a> <a title="AJG_Vol.109_No.2 page 121" href="http://viewer.zmags.com/publication/3da21923?page=121"> 222 Lichtenstein et al. In conclusion, </a> <a title="AJG_Vol.109_No.2 page 122" href="http://viewer.zmags.com/publication/3da21923?page=122"> 13. Mariette X, Matucci-Cerinic M, Pavelka K et a</a> <a title="AJG_Vol.109_No.2 page 123" href="http://viewer.zmags.com/publication/3da21923?page=123"> 224 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.2 page 124" href="http://viewer.zmags.com/publication/3da21923?page=124"> controlling for present disease or dysfunction (4</a> <a title="AJG_Vol.109_No.2 page 125" href="http://viewer.zmags.com/publication/3da21923?page=125"> 226 Lackner et al. summed total score is </a> <a title="AJG_Vol.109_No.2 page 126" href="http://viewer.zmags.com/publication/3da21923?page=126"> clinical variables. To accomplish this, hierarchi</a> <a title="AJG_Vol.109_No.2 page 127" href="http://viewer.zmags.com/publication/3da21923?page=127"> 228 Lackner et al. FUNCTIONAL GI DISORDERS </a> <a title="AJG_Vol.109_No.2 page 128" href="http://viewer.zmags.com/publication/3da21923?page=128"> Self-Rated Health and IBS 229 Table 3. Resu</a> <a title="AJG_Vol.109_No.2 page 129" href="http://viewer.zmags.com/publication/3da21923?page=129"> Self-rated health Mental Perceived stress (PSS) </a> <a title="AJG_Vol.109_No.2 page 130" href="http://viewer.zmags.com/publication/3da21923?page=130"> a way of flushing out the reasons for which patie</a> <a title="AJG_Vol.109_No.2 page 131" href="http://viewer.zmags.com/publication/3da21923?page=131"> 232 Lackner et al. Christopher Radziwon, </a> <a title="AJG_Vol.109_No.2 page 132" href="http://viewer.zmags.com/publication/3da21923?page=132"> 36. Drossman DA. A Biopsychosocial Approach to Ir</a> <a title="AJG_Vol.109_No.2 page 133" href="http://viewer.zmags.com/publication/3da21923?page=133"> 234 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.2 page 134" href="http://viewer.zmags.com/publication/3da21923?page=134"> conditions (2,3), improve satisfaction with care </a> <a title="AJG_Vol.109_No.2 page 135" href="http://viewer.zmags.com/publication/3da21923?page=135"> 236 Khanna et al. FUNCTIONAL GI DISORDERS T</a> <a title="AJG_Vol.109_No.2 page 136" href="http://viewer.zmags.com/publication/3da21923?page=136"> Interrater reliability was measured using the </a> <a title="AJG_Vol.109_No.2 page 137" href="http://viewer.zmags.com/publication/3da21923?page=137"> 238 Khanna et al. FUNCTIONAL GI DISORDERS T</a> <a title="AJG_Vol.109_No.2 page 138" href="http://viewer.zmags.com/publication/3da21923?page=138"> Domain </a> <a title="AJG_Vol.109_No.2 page 139" href="http://viewer.zmags.com/publication/3da21923?page=139"> 240 Khanna et al. throat burn), (iii) bel</a> <a title="AJG_Vol.109_No.2 page 140" href="http://viewer.zmags.com/publication/3da21923?page=140"> Table 4. Results of quality scoring Number of ins</a> <a title="AJG_Vol.109_No.2 page 141" href="http://viewer.zmags.com/publication/3da21923?page=141"> 242 Khanna et al. FUNCTIONAL GI DISORDERS F</a> <a title="AJG_Vol.109_No.2 page 142" href="http://viewer.zmags.com/publication/3da21923?page=142"> patients should carefully review the resulting it</a> <a title="AJG_Vol.109_No.2 page 143" href="http://viewer.zmags.com/publication/3da21923?page=143"> 244 Khanna et al. received grant support </a> <a title="AJG_Vol.109_No.2 page 144" href="http://viewer.zmags.com/publication/3da21923?page=144"> 33. Revicki DA, Rentz AM, Dubois D et al. Gastrop</a> <a title="AJG_Vol.109_No.2 page 145" href="http://viewer.zmags.com/publication/3da21923?page=145"> 246 Khanna et al. FUNCTIONAL GI DISORDERS 8</a> <a title="AJG_Vol.109_No.2 page 146" href="http://viewer.zmags.com/publication/3da21923?page=146"> 134. Brunner HI, Johnson AL, Barron AC et al. Gas</a> <a title="AJG_Vol.109_No.2 page 147" href="http://viewer.zmags.com/publication/3da21923?page=147"> 248 Khanna et al. APPENDIX 1 List of sear</a> <a title="AJG_Vol.109_No.2 page 148" href="http://viewer.zmags.com/publication/3da21923?page=148"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 149" href="http://viewer.zmags.com/publication/3da21923?page=149"> 250 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.2 page 150" href="http://viewer.zmags.com/publication/3da21923?page=150"> the United States was estimated to be approximate</a> <a title="AJG_Vol.109_No.2 page 151" href="http://viewer.zmags.com/publication/3da21923?page=151"> 252 Sethi et al. 60,000 50,000 40,000</a> <a title="AJG_Vol.109_No.2 page 152" href="http://viewer.zmags.com/publication/3da21923?page=152"> Inpatient Burden of Constipation 253 Table </a> <a title="AJG_Vol.109_No.2 page 153" href="http://viewer.zmags.com/publication/3da21923?page=153"> <1 <1–17 18 – 44 45 – 64 </a> <a title="AJG_Vol.109_No.2 page 154" href="http://viewer.zmags.com/publication/3da21923?page=154"> discharges, the entire aggregate hospital costs i</a> <a title="AJG_Vol.109_No.2 page 155" href="http://viewer.zmags.com/publication/3da21923?page=155"> 256 Sethi et al. Study Highlights FUNCTI</a> <a title="AJG_Vol.109_No.2 page 156" href="http://viewer.zmags.com/publication/3da21923?page=156"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 157" href="http://viewer.zmags.com/publication/3da21923?page=157"> 258 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.2 page 158" href="http://viewer.zmags.com/publication/3da21923?page=158"> Neuroendocrine Cells in Refractory Celiac Disease</a> <a title="AJG_Vol.109_No.2 page 159" href="http://viewer.zmags.com/publication/3da21923?page=159"> 260 Di Sabatino et al. COLON/SMALL BOWEL Ta</a> <a title="AJG_Vol.109_No.2 page 160" href="http://viewer.zmags.com/publication/3da21923?page=160"> dilution; Dako Cytomation). Counts were performed</a> <a title="AJG_Vol.109_No.2 page 161" href="http://viewer.zmags.com/publication/3da21923?page=161"> 262 Di Sabatino et al. COLON/SMALL BOWEL Im</a> <a title="AJG_Vol.109_No.2 page 162" href="http://viewer.zmags.com/publication/3da21923?page=162"> Neuroendocrine Cells in Refractory Celiac Disease</a> <a title="AJG_Vol.109_No.2 page 163" href="http://viewer.zmags.com/publication/3da21923?page=163"> 264 Di Sabatino et al. COLON/SMALL BOWEL Fi</a> <a title="AJG_Vol.109_No.2 page 164" href="http://viewer.zmags.com/publication/3da21923?page=164"> Neuroendocrine Cells in Refractory Celiac Disease</a> <a title="AJG_Vol.109_No.2 page 165" href="http://viewer.zmags.com/publication/3da21923?page=165"> 266 Di Sabatino et al. COLON/SMALL BOWEL 3.</a> <a title="AJG_Vol.109_No.2 page 166" href="http://viewer.zmags.com/publication/3da21923?page=166"> small bowel mucosa despite a gluten-containing di</a> <a title="AJG_Vol.109_No.2 page 167" href="http://viewer.zmags.com/publication/3da21923?page=167"> 268 Di Sabatino et al. * 1000 900 800</a> <a title="AJG_Vol.109_No.2 page 168" href="http://viewer.zmags.com/publication/3da21923?page=168"> Study Highlights WHAT IS CURRENT KNOWLEDGE 3Neur</a> <a title="AJG_Vol.109_No.2 page 169" href="http://viewer.zmags.com/publication/3da21923?page=169"> 270 ORIGINAL CONTRIBUTIONS </a> <a title="AJG_Vol.109_No.2 page 170" href="http://viewer.zmags.com/publication/3da21923?page=170"> Figure 1. Typical Andean landscape, depicting the</a> <a title="AJG_Vol.109_No.2 page 171" href="http://viewer.zmags.com/publication/3da21923?page=171"> 272 Zevallos et al. COLON/SMALL BOWEL Table</a> <a title="AJG_Vol.109_No.2 page 172" href="http://viewer.zmags.com/publication/3da21923?page=172"> enterocytes. Negative alterations of a combinatio</a> <a title="AJG_Vol.109_No.2 page 173" href="http://viewer.zmags.com/publication/3da21923?page=173"> 274 Zevallos et al. COLON/SMALL BOWEL Table</a> <a title="AJG_Vol.109_No.2 page 174" href="http://viewer.zmags.com/publication/3da21923?page=174"> VH:CD measurements within normal limits before an</a> <a title="AJG_Vol.109_No.2 page 175" href="http://viewer.zmags.com/publication/3da21923?page=175"> 276 Zevallos et al. 8 6 4 2 </a> <a title="AJG_Vol.109_No.2 page 176" href="http://viewer.zmags.com/publication/3da21923?page=176"> 1.0 0.8 0.6 0.4 Degree of villous atrophy 0.</a> <a title="AJG_Vol.109_No.2 page 177" href="http://viewer.zmags.com/publication/3da21923?page=177"> 278 Zevallos et al. Study Highlights COL</a> <a title="AJG_Vol.109_No.2 page 178" href="http://viewer.zmags.com/publication/3da21923?page=178"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 179" href="http://viewer.zmags.com/publication/3da21923?page=179"> 280 Pierdomenico et al. PEDIATRICS from sup</a> <a title="AJG_Vol.109_No.2 page 180" href="http://viewer.zmags.com/publication/3da21923?page=180"> Tween-20) containing 5% non-fat dry milk. Anti-RI</a> <a title="AJG_Vol.109_No.2 page 181" href="http://viewer.zmags.com/publication/3da21923?page=181"> 282 Pierdomenico et al. PEDIATRICS CD C </a> <a title="AJG_Vol.109_No.2 page 182" href="http://viewer.zmags.com/publication/3da21923?page=182"> C CD ileum Densitomet</a> <a title="AJG_Vol.109_No.2 page 183" href="http://viewer.zmags.com/publication/3da21923?page=183"> 284 Pierdomenico et al. PEDIATRICS 120 100</a> <a title="AJG_Vol.109_No.2 page 184" href="http://viewer.zmags.com/publication/3da21923?page=184"> IFNγ – + + + z-VAD – </a> <a title="AJG_Vol.109_No.2 page 185" href="http://viewer.zmags.com/publication/3da21923?page=185"> 286 Pierdomenico et al. PEDIATRICS The colo</a> <a title="AJG_Vol.109_No.2 page 186" href="http://viewer.zmags.com/publication/3da21923?page=186"> 7. Yuan J, Kroemer G. Alternative cell death mec</a> <a title="AJG_Vol.109_No.2 page 187" href="http://viewer.zmags.com/publication/3da21923?page=187"> 288 LETTERS TO THE EDITOR </a> <a title="AJG_Vol.109_No.2 page 188" href="http://viewer.zmags.com/publication/3da21923?page=188"> For the data in Table 1, gastroenterolo- gists </a> <a title="AJG_Vol.109_No.2 page 189" href="http://viewer.zmags.com/publication/3da21923?page=189"> 290 Letters to the Editor Remove the polyp</a> <a title="AJG_Vol.109_No.2 page 190" href="http://viewer.zmags.com/publication/3da21923?page=190"> Histiocytic Sarcoma: The First Reported Case of P</a> <a title="AJG_Vol.109_No.2 page 191" href="http://viewer.zmags.com/publication/3da21923?page=191"> 292 Letters to the Editor cytic marker (CD</a> <a title="AJG_Vol.109_No.2 page 192" href="http://viewer.zmags.com/publication/3da21923?page=192"> (4,5). Because her prodrome phase lasted approxim</a> <a title="AJG_Vol.109_No.2 page 193" href="http://viewer.zmags.com/publication/3da21923?page=193"> 294 Letters to the Editor </a> <a title="AJG_Vol.109_No.2 page 194" href="http://viewer.zmags.com/publication/3da21923?page=194"> Figure 3. Imaging examinations confirmed the perfo</a> <a title="AJG_Vol.109_No.2 page 195" href="http://viewer.zmags.com/publication/3da21923?page=195"> 296 Letters to the Editor stents had simil</a> <a title="AJG_Vol.109_No.2 page 196" href="http://viewer.zmags.com/publication/3da21923?page=196"> stent change intervals. Gastrointest Endos</a> <a title="AJG_Vol.109_No.2 page 197" href="http://viewer.zmags.com/publication/3da21923?page=197"> 298 Letters to the Editor REFERENCES 1. L</a> <a title="AJG_Vol.109_No.2 page 198" href="http://viewer.zmags.com/publication/3da21923?page=198"> CONFLICT OF INTEREST The authors declare no confl</a> <a title="AJG_Vol.109_No.2 page 199" href="http://viewer.zmags.com/publication/3da21923?page=199"> 300 Letters to the Editor which have very </a> <a title="AJG_Vol.109_No.2 page 200" href="http://viewer.zmags.com/publication/3da21923?page=200"> nature publishing group </a> <a title="AJG_Vol.109_No.2 page 201" href="http://viewer.zmags.com/publication/3da21923?page=201"> 302 ERRATA, CORRIGENDA AND RETRACTIONS </a> <a title="AJG_Vol.109_No.2 page 202" href="http://viewer.zmags.com/publication/3da21923?page=202"> CLASSIFIEDS GASTROENTEROLOGY/IBD/MOTILITY FACULTY</a> <a title="AJG_Vol.109_No.2 page 203" href="http://viewer.zmags.com/publication/3da21923?page=203"> Gastroenterologist Opportunity Available Benefis H</a> <a title="AJG_Vol.109_No.2 page 204" href="http://viewer.zmags.com/publication/3da21923?page=204"> ScopeGuide Real-time, 3D visualization of the sco</a> <a title="AJG_Vol.109_No.2 page 205" href="http://viewer.zmags.com/publication/3da21923?page=205"> CRH O'Regan System Non-Surgical Treatment for Hem</a>